Low-Dose Darbepoetin α Attenuates Progression of a Mouse Model of Aristolochic Acid Nephropathy through Early Tubular Protection

2010 ◽  
Vol 114 (2) ◽  
pp. e69-e81 ◽  
Author(s):  
Yuki Hamano ◽  
Takahiro Aoki ◽  
Ryota Shirai ◽  
Megumi Hatano ◽  
Ryota Kimura ◽  
...  
Keyword(s):  
Mouse Model ◽  
Low Dose ◽  
Aristolochic Acid ◽  
Aristolochic Acid Nephropathy

scholarly journals Protective role of relaxin in a mouse model of aristolochic acid nephropathy

2019 ◽  
Vol 115 ◽  
pp. 108917 ◽  
Author(s):  
Xiu Yang ◽  
Daniel Thorngren ◽  
Qi Chen ◽  
Ming Wang ◽  
Xiangcheng Xie
Keyword(s):  
Mouse Model ◽  
Aristolochic Acid ◽  
Protective Role ◽  
Aristolochic Acid Nephropathy

scholarly journals Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy

2012 ◽  
Vol 82 (10) ◽  
pp. 1105-1113 ◽  
Author(s):  
Thomas E.R. Baudoux ◽  
Agnieszka A. Pozdzik ◽  
Volker M. Arlt ◽  
Eric G. De Prez ◽  
Marie-Hélène Antoine ◽  
...  
Keyword(s):  
Mouse Model ◽  
Acute Tubular Necrosis ◽  
Aristolochic Acid ◽  
Tubular Necrosis ◽  
Aristolochic Acid Nephropathy

scholarly journals MP083PROTECTIVE ROLES OF RELAXIN IN A MOUSE MODEL OF ARISTOLOCHIC ACID NEPHROPATHY

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii456-iii456
Author(s):  
Xiangcheng xie ◽  
Xiu Yang ◽  
Xiao Fei ◽  
Ming Wang
Keyword(s):  
Mouse Model ◽  
Aristolochic Acid ◽  
Aristolochic Acid Nephropathy

scholarly journals Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy

PLoS ONE ◽  
2017 ◽  
Vol 12 (8) ◽  
pp. e0183604 ◽  
Author(s):  
Inès Jadot ◽  
Vanessa Colombaro ◽  
Blanche Martin ◽  
Isabelle Habsch ◽  
Olivia Botton ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Mouse Model ◽  
Aristolochic Acid ◽  
Aristolochic Acid Nephropathy ◽  
Nitric Oxide Bioavailability

scholarly journals Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy

FEBS Open Bio ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 507-518
Author(s):  
Takeo Ishii ◽  
Tomohiro Kumagae ◽  
Hiromichi Wakui ◽  
Shingo Urate ◽  
Shohei Tanaka ◽  
...  
Keyword(s):  
Mouse Model ◽  
Aristolochic Acid ◽  
Xanthine Oxidoreductase ◽  
Oxidoreductase Activity ◽  
Aristolochic Acid Nephropathy

Enzymes Metabolizing Aristolochic Acid and their Contribution to the Development of Aristolochic Acid Nephropathy and Urothelial Cancer

2013 ◽  
Vol 14 (6) ◽  
pp. 695-705 ◽  
Author(s):  
Marie Stiborova ◽  
Vaclav Martínek ◽  
Eva Frei ◽  
Volker Arlt ◽  
Heinz Schmeiser
Keyword(s):  
Urothelial Cancer ◽  
Aristolochic Acid ◽  
Aristolochic Acid Nephropathy

scholarly journals Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model

2015 ◽  
Vol 138 ◽  
pp. 70-79 ◽  
Author(s):  
Megan Stringer ◽  
Irushi Abeysekera ◽  
Karl J. Dria ◽  
Randall J. Roper ◽  
Charles R. Goodlett
Keyword(s):  
Down Syndrome ◽  
Cognitive Impairment ◽  
Mouse Model ◽  
Low Dose ◽  
Egcg Treatment

scholarly journals Advantages of Repeated Low Dose against Single High Dose of Kainate in C57BL/6J Mouse Model of Status Epilepticus: Behavioral and Electroencephalographic Studies

PLoS ONE ◽  
2014 ◽  
Vol 9 (5) ◽  
pp. e96622 ◽  
Author(s):  
Karen Tse ◽  
Sreekanth Puttachary ◽  
Edward Beamer ◽  
Graeme J. Sills ◽  
Thimmasettappa Thippeswamy
Keyword(s):  
Status Epilepticus ◽  
Mouse Model ◽  
Low Dose ◽  
High Dose ◽  
Single High Dose
Sign in / Sign up

Export Citation Format

Share Document